Home
/ CureVac
/ Competitors

CureVac Competitors and Similar CompaniesClear all

CureVac's competitors and similar companies include Stemirna, RNACure, Moderna, Regulus Therapeutics, Sarepta Therapeutics and Alnylam.

	CureVac CureVac is a biotechnology company offering messenger RNA (mRNA) technology.	Stemirna Stemirna is an RNA technology-based drug development company.	RNACure RNACure is a company that develops a messenger RNA (mRNA) drug discovery platform made from mRNA synthesis.	Moderna Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine.	Regulus Therapeutics Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.	Sarepta Therapeutics Sarepta Therapeutics is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapeutics, gene therapy and, other genetic therapeutic modalities for the treatment of rare diseases.	Alnylam Alnylam is a biopharmaceutical company that develops ribonucleic acid interference (RNAi) therapeutics for hepatic porphyria, primary hyperoxaluria type 1 (PH1), cardiovascular, and polyneuropathy treatments.
Founding Date	Founding Date 2000	Founding Date 2016	Founding Date 2019	Founding Date 2010	Founding Date 2007	Founding Date 1980	Founding Date 2002
Type	Type Public	Type Private	Type Private	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech clinical research drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development genetics	Tags Healthcare biotech pharma
Locations	Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US	Locations Shanghai, CN HQ	Locations Shanghai, CN HQ	Locations Cambridge, US HQ Melbourne, AU Paris, FR München, DE Tokyo, JP Seoul, KR Warszawa, PL see more	Locations San Diego, US HQ	Locations Cambridge, US HQ Dublin, IE Zug, CH Providence, US	Locations Cambridge, US HQ Paris, FR Milan, IT Tokyo, JP Amsterdam, NL Stockholm, SE Zug, CH see more
Employees	Employees 82517% decrease	Employees N/A	Employees 5	Employees 5,8004% increase	Employees 2462% decrease	Employees 1,31413% increase	Employees 1,32324% increase
Valuation ($)	Valuation ($) 648.3 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 21.2 b	Valuation ($) 105.4 m	Valuation ($) 12.4 b	Valuation ($) 36.5 b
Financial
Revenue (est.)	Revenue (est.) €535.2m (FY, 2024)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $1.9b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $2.2b (FY, 2025)	Revenue (est.) $3.7b (FY, 2025)
Cost of goods	Cost of goods €9.7m (FY, 2024)	Cost of goods N/A	Cost of goods N/A	Cost of goods $868m (FY, 2025)	Cost of goods N/A	Cost of goods $25.5m (FY, 2025)	Cost of goods $677.2m (FY, 2025)
Gross profit	Gross profit €534.4m (FY, 2024)	Gross profit N/A	Gross profit N/A	Gross profit $1.1b (FY, 2025)	Gross profit N/A	Gross profit $2.2b (FY, 2025)	Gross profit $3b (FY, 2025)
Net income	Net income €162.2m (FY, 2024)	Net income N/A	Net income N/A	Net income ($2.8b) (FY, 2025)	Net income ($46.4m) (FY, 2024)	Net income ($713.4m) (FY, 2025)	Net income $313.7m (FY, 2025)
Operating ⚠
Patent Applications	Patent Applications 500 (Mar, 2020)	Patent Applications 2 (May, 2020)	Patent Applications N/A	Patent Applications 430 (FY, 2021)	Patent Applications N/A	Patent Applications N/A	Patent Applications N/A
Patents Issued	Patents Issued 233 (May, 2020)	Patents Issued 2 (May, 2020)	Patents Issued N/A	Patents Issued 270 (FY, 2020)	Patents Issued 300 (FY, 2016)	Patents Issued N/A	Patents Issued N/A
Platforms	Platforms N/A	Platforms 3 (May, 2020)	Platforms 2 (May, 2020)	Platforms N/A	Platforms N/A	Platforms N/A	Platforms N/A
Funding
Total funding raised	Total funding raised $ 1.1b	Total funding raised $ 206.5m	Total funding raised N/A	Total funding raised $ 1.8b	Total funding raised $ 10m	Total funding raised N/A	Total funding raised $ 1.5b